Up-regulation of protease-activated receptor-1 in diabetic glomerulosclerosis

Biochemical and Biophysical Research Communications

Volumn 384, Issue 2, 2009, Pages 173-179

  Sakai, Takumi ^a   Nambu, Tadahiro ^a   Katoh, Masahiro ^a   Uehara, Sayuri ^a   Fukuroda, Takahiro ^a   Nishikibe, Masaru ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Diabetic nephropathy; Glomerulosclerosis; PAR 1; Thrombin

Indexed keywords

ALBUMIN; MESSENGER RNA; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GENE EXPRESSION PROFILING; GLOMERULUS; HYPERGLYCEMIA; IN SITU HYBRIDIZATION; KIDNEY; KIDNEY HYPERTROPHY; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; UPREGULATION; URINARY EXCRETION;

ANIMALS; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; KIDNEY GLOMERULUS; MICE; MICE, INBRED STRAINS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; RNA, MESSENGER; UP-REGULATION;

MUS;

EID: 65549160617     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.04.105     Document Type: Article

References (25)

1. Eto M., Barandiér C., Rathgeb L., Kozai T., Joch H., Yang Z., and Lüscher T.F. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways. Circ. Res. 89 (2001) 583-590
2. McNamara C.A., Sarembock I.J., Gimple L.W., Fenton II J.W., Coughlin S.R., and Owens G.K. Thrombin stimulates proliferation of cultured rat smooth muscle cells by a proteolytically activated receptor. J. Clin. Invest. 91 (1993) 94-98
3. Chambers R.C., Leoni P., Blanc-Brude O.P., Wembridge D.E., and Laurent G.J. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J. Biol. Chem. 45 (2000) 35584-35591
4. Grabham P., and Cunningham D.D. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J. Neurochem. 64 (1995) 583-591
5. Kahn M.L., Hammes S.R., Botka C., and Coughlin S.R. Genes and locus structure and chromosomal localization of the protease-activated receptor gene family. J. Biol. Chem. 273 (1998) 23290-23296
6. Grandaliano G., Gesualdo L., Ranieri E., Monno R., and Schena F.P. Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis. Am. J. Kidney Dis. 35 (2000) 726-738
7. Cunningham M.A., Rondeau E., Chen X., Coughlin S.R., Holdsworth S.R., and Tipping P.G. Protease activated receptor-1 mediated, fibrin independent pro-inflammatory actions of thrombin in crescentic glomerulonphritis. J. Exp. Med. 191 (2000) 455-462
8. Tognetto M., D'Andrea M.R., Trevisani M., Guerrini R., Salvadori S., Spisani L., Daniele C., Andrade-Gordon P., Geppetti P., and Harrison S. Protease-activated receptor-1 activation contracts the isolated human renal artery in vitro. Br. J. Pharmacol. 139 (2003) 21-37
9. Moffatt J.D., and Cocks T.M. Endothelium-dependent and -independent responses to protease-activated receptor-2 activation in mouse isolated renal arteries. Br. J. Phalmacol. 125 (1998) 591-594
10. Gui Y., Loutzenhiser R., and Hollenberg M.D. Bidirectional regulation of renal hemodynamics by activation of PAR1 and PAR2 in isolated perfused rat kidney. Am. J. Physiol. 285 (2003) F95-F104
11. Fuller J.H., Keen H., Jarrett R.J., Omer T., Meade T.W., Chakrabarti R., North W.R., and Stirling Y. Haemostatic variables associated with diabetes and its complications. Br. Med. J. 2 (1979) 964-966
12. Tada H., Kuboki K., Oshima Y., Takeuchi S., and Isogai S. Increased intraglomerular thrombin formation in microangiopathy. Diabetes Res. Clin. Pract. 8 (1989) 121-125
13. Asakawa H., Tokunaga K., and Kawakami F. Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J. Diabetes Complications 14 (2000) 121-126
14. Like A., Lavine R., Poffenbarger P., and Chick W. Studies in the diabetic mutant mouse. Am. J. Pathol. 66 (1972) 193-204
15. Cohen M.P., Clements R.S., Hud E., Cohen J.A., and Ziyadeh F.N. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy. Exp. Nephrol. 4 (1996) 166-171
16. Cohen M.P., Lautenslager G.T., and Shearman C.W. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic db/db mice. Metabolism 12 (2001) 1435-1440
17. Baelde J.J., Bergijk E.C., Hoedemaeker P.J., Heer E., and Bruijn J.A. Optimal method for RNA extraction from mouse glomeruli. Nephrol. Dial. Transplant. 9 (1994) 304-308
18. Fan Q., Shike T., Shigehara T., Tanimoto T., Gohda T., Makita Y., Wang L.N., Horikoshi S., and Tomino Y. Gene expression profiles in diabetic KK/Ta mice. Kidney Int. 64 (2003) 1978-1985
19. Wada J., Zhang H., Tsuchiyama Y., Hiragushi K., Hida K., Shikata K., Kanwar Y.S., and Makino H. Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int. 59 (2001) 1363-1373
20. Susztak K., Bottinger E., Novetsky A., Liang D., Zhu Y., Ciccone E., Wu D., Dunn S., McCue O., and Sharma K. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53 (2004) 784-794
21. Takemoto M., Asker N., Gerhardt H., Lundkvist A., Johansson B.R., Saito Y., and BetsholtZ C. A new method for large scale isolation of kidney glomeruli from mice. Am. J. Pathol. 61 (2002) 799-805
22. Makino H., Miyamot Y., Sawai K., Kiyoshi M., Mukoyama M., Nakao K., Yoshimasa Y., and Suga S. Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone. Diabetes 55 (2006) 2747-2756
23. Kaizuka M., Yamabe H., Osawa H., Okumura K., and Fujimoto N. Thrombin stimulates synthesis of type IV collagen and tissue inhibitor of metalloproteinase-1 by culture human mesangial cells. J. Am. Soc. Nephrol. 10 (1999) 1516-1523
24. Sevastos J., Kennedy S.E., Davis D.R., Sam M., Peake P.W., Charlesworth J.A., Mackman N., and Erlich J.H. Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. Blood 109 (2007) 577-583
25. Riser B.L., Denichilo M., Cortes P., Baker C., Grondin J.M., Yee J., and Narins R.G. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomeruloscleosis. J. Am. Soc. Nephrol. 11 (2000) 25-38